Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-3-15
pubmed:abstractText
The effects of cigarette smoking and parity on the development of symptomatic gall bladder disease remain controversial. These relations have been examined in a cohort of 46,000 women followed for up to 19 years during the Royal College of General Practitioners' (RCGP) oral contraception study. During follow up, 1087 women were recorded as experiencing their first ever episode of symptomatic cholelithiasis (International Classification of Diseases, 8th revision (ICD-8) 574) or cholecystitis (ICD-8 575). Smokers were more likely to develop symptomatic gall bladder disease than non-smokers (relative risk 1.19; 95% confidence intervals (95% CI) 1.06 to 1.34) and there was a significant trend with the number of cigarettes smoked daily (test for trend chi 2 = 7.58, p < 0.01). This relation was most apparent among never users of oral contraceptives, although similar trends were found among current and former users. A significant direct relation between symptomatic gall bladder disease and parity was also found (test for trend chi 2 = 21.89, p < 0.001). When all were examined together a trend of increasing risk with lower social class was also found (test for trend chi 2 = 5.72, p = 0.02). Current users of oral contraceptives had a moderately increased risk of symptomatic gall bladder disease (relative risk 1.15; 95% CI 0.99 to 1.34), unlike former users (relative risk 1.03; 95% CI 0.90 to 1.18). These results suggest that smoking and parity are important risk factors for the development of symptomatic gall bladder disease in women.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-1346283, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-1499446, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-1797601, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-1862802, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-2022415, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-2369240, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-2761600, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-2785475, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-3044911, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-3275565, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-3496013, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-3625039, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-3892163, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-3943697, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-6127462, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-6281127, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-6428548, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-6428962, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-7166683, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-7231462, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-7959216, http://linkedlifedata.com/resource/pubmed/commentcorrection/8307429-993236
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Behavior, http://linkedlifedata.com/resource/pubmed/keyword/Cohort Analysis, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods, http://linkedlifedata.com/resource/pubmed/keyword/Demographic Factors, http://linkedlifedata.com/resource/pubmed/keyword/Developed Countries, http://linkedlifedata.com/resource/pubmed/keyword/Diseases, http://linkedlifedata.com/resource/pubmed/keyword/Europe, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Fertility, http://linkedlifedata.com/resource/pubmed/keyword/Fertility Measurements, http://linkedlifedata.com/resource/pubmed/keyword/GALLBLADDER DISEASES, http://linkedlifedata.com/resource/pubmed/keyword/Northern Europe, http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, http://linkedlifedata.com/resource/pubmed/keyword/Parity, http://linkedlifedata.com/resource/pubmed/keyword/Population, http://linkedlifedata.com/resource/pubmed/keyword/Population Dynamics, http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology, http://linkedlifedata.com/resource/pubmed/keyword/Research Report, http://linkedlifedata.com/resource/pubmed/keyword/SMOKING, http://linkedlifedata.com/resource/pubmed/keyword/United Kingdom
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0017-5749
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
107-11
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Cigarette smoking and parity as risk factors for the development of symptomatic gall bladder disease in women: results of the Royal College of General Practitioners' oral contraception study.
pubmed:affiliation
Department of Therapeutics, Royal College of General Practitioners, Manchester.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't